CASR and hyperphosphatemia: The Nuf mouse model of ADH1 has a mutation (Leu723Gln) in the homologous CaSR Leu723 residue that similarly results in enhanced CaSR signaling17 with biochemical features of hypoparathyroidism, including hypocalcemia, inappropriately low plasma PTH, and hyperphosphatemia.17